SMG vs BIOX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 03, 2026
SMG
BIOX
Investment Advisor Scores
BIOX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | SMG | BIOX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 17.0648 | 14.9925 | BIOX |
| PEG Ratio | 0.9699 | 1.9521 | SMG |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -1.3% | -35.9% | SMG |
| Earnings Growth | -25.4% | 34.4% | BIOX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 52.4/100 | 44.3/100 | SMG |
| Profit Margin | 2.1% | -96.9% | SMG |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
SMG
NeutralMixed signals - no dominant trend phase, RSI 46
BIOX
NeutralMixed signals - no dominant trend phase, RSI 52
Fundamentals Snapshot
| Metric | SMG | BIOX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 13.8 | 7.2 |
| Trailing P/E | 25.1 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | -0.4% |
| Gross Margin | 0.3% | 0.4% |
| Operating Margin | 0.1% | -0.2% |
| EPS | 2.72 | -1.11 |
| Dividend Yield | 0.01% | — |